| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |

















From the Istituto Dermopatico dellImmacolata,*Rome, Italy; the Department of Experimental Medicine,
University of LAquila, LAquila, Italy; the Department of Medical Physiopathology,
University La Sapienza, Rome, Italy; the Divisions of Haematology and Pathology,
Ospedale Bambino Gesù, Rome, Italy; the Department of Pediatric Haematology and Oncology,¶Istituto di Ricovero e Cura a Carattere Scientifico Giannina Gaslini, Genova, Italy; the Institute of Biomedical Technology,**Consiglio Nazionale Delle Ricerche, Milan, Italy; the Department of Pediatrics,
University Tor Vergata, Rome, Italy; and the Department of Medicine and Therapy,||University of Aberdeen, Aberdeen, Scotland
Autosomal-recessive osteopetrosis is a severe genetic disease caused by osteoclast failure. Approximately 50% of the patients harbor mutations of the ATP6i gene, encoding for the osteoclast-specific a3 subunit of V-ATPase. We found inactivating ATP6i mutations in four patients, and three of these were novel. Patients shared macrocephaly, growth retardation and optic nerve alteration, osteosclerotic and endobone patterns, and high alkaline phosphatase and parathyroid hormone levels. Bone biopsies revealed primary spongiosa lined with active osteoblasts and high numbers of tartrate-resistant acid phosphatase (TRAP)-positive, a3 subunit-negative, morphologically unremarkable osteoclasts, some of which located in shallow Howship lacunae. Scarce hematopoietic cells and abundant fibrous tissue containing TRAP-positive putative osteoclast precursors were noted. In vitro osteoclasts were a3-negative, morphologically normal, with prominent clear zones and actin rings, and TRAP activity more elevated than in control patients. Podosomes,
Vß3 receptor, c-Src, and PYK2 were unremarkable. Consistent with the finding in the bone biopsies, these cells excavated pits faintly stained with toluidine blue, indicating inefficient bone resorption. Bone marrow transplantation was successful in all patients, and posttransplant osteoclasts showed rescue of a3 subunit immunoreactivity.
This article has been cited by other articles:
![]() |
M. A. Karsdal and K. Henriksen Osteoclasts Control Osteoblast Activity IBMS BoneKEy, January 1, 2007; 4(1): 19 - 24. [Full Text] [PDF] |
||||
![]() |
N. Ochotny, A. Van Vliet, N. Chan, Y. Yao, M. Morel, N. Kartner, H. P. von Schroeder, J. N. M. Heersche, and M. F. Manolson Effects of Human a3 and a4 Mutations That Result in Osteopetrosis and Distal Renal Tubular Acidosis on Yeast V-ATPase Expression and Activity J. Biol. Chem., September 8, 2006; 281(36): 26102 - 26111. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Del Fattore, B Peruzzi, N Rucci, I Recchia, A Cappariello, M Longo, D Fortunati, P Ballanti, M Iacobini, M Luciani, et al. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment J. Med. Genet., April 1, 2006; 43(4): 315 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Frattini, H. C. Blair, M. G. Sacco, F. Cerisoli, F. Faggioli, E. M. Cato, A. Pangrazio, A. Musio, F. Rucci, C. Sobacchi, et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero PNAS, October 11, 2005; 102(41): 14629 - 14634. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Teti New Concepts in Osteoclast Pathophysiology IBMS BoneKEy, June 1, 2005; 2(6): 17 - 22. [Full Text] [PDF] |
||||
![]() |
M. A. Karsdal, K. Henriksen, M. G. Sorensen, J. Gram, S. Schaller, M. H. Dziegiel, A.-M. Heegaard, P. Christophersen, T. J. Martin, C. Christiansen, et al. Acidification of the Osteoclastic Resorption Compartment Provides Insight into the Coupling of Bone Formation to Bone Resorption Am. J. Pathol., February 1, 2005; 166(2): 467 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tolar, S. L. Teitelbaum, and P. J. Orchard Osteopetrosis N. Engl. J. Med., December 30, 2004; 351(27): 2839 - 2849. [Full Text] [PDF] |
||||
![]() |
N. Utku, A. Boerner, A. Tomschegg, F. Bennai-Sanfourche, G.-C. Bulwin, T. Heinemann, J. Loehler, R. S. Blumberg, and H.-D. Volk TIRC7 Deficiency Causes In Vitro and In Vivo Augmentation of T and B Cell Activation and Cytokine Response J. Immunol., August 15, 2004; 173(4): 2342 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Henriksen, J. Gram, S. Schaller, B. H. Dahl, M. H. Dziegiel, J. Bollerslev, and M. A. Karsdal Characterization of Osteoclasts from Patients Harboring a G215R Mutation in ClC-7 Causing Autosomal Dominant Osteopetrosis Type II Am. J. Pathol., May 1, 2004; 164(5): 1537 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. H. Lerner NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION Crit. Rev. Oral. Biol. Med., March 1, 2004; 15(2): 64 - 81. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |